These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36802345)

  • 21. CT assessment of breast cancer for pathological involvement of four or more axillary nodes.
    Ogino I; Tayama Y; Arai M; Inoue T; Shimizu D; Ishikawa T
    Breast Cancer; 2012 Apr; 19(2):125-30. PubMed ID: 20697857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer.
    Has Simsek D; Emiroglu S; Yilmaz R; Bayram A; Isik EG; Tukenmez M; Kuyumcu S; Dursun M; Muslumanoglu M; Cabioglu N
    Clin Nucl Med; 2022 Nov; 47(11):e682-e688. PubMed ID: 35835147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer.
    Trinh L; Miyake KK; Dirbas FM; Kothary N; Horst KC; Lipson JA; Carpenter C; Thompson AC; Ikeda DM
    Breast J; 2016 Jul; 22(4):390-6. PubMed ID: 27061012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
    Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Han X; Jin S; Yang H; Zhang J; Huang Z; Han J; He C; Guo H; Yang Y; Shan M; Zhang G
    Br J Radiol; 2021 Sep; 94(1125):20210520. PubMed ID: 34415197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial.
    Zhu T; Huang YH; Li W; Wu CG; Zhang YM; Zheng XX; Zhang TF; Lin YY; Liu ZY; Ye GL; Lin Y; Wu ZY; Wang K
    Br J Cancer; 2024 Sep; 131(4):692-701. PubMed ID: 38918556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
    Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
    Cheng J; Wang Y; Mo M; Bao X; Zhang Y; Liu G; Zhang J; Geng D
    Oncotarget; 2015 Oct; 6(30):29388-95. PubMed ID: 26336821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics model based on features of axillary lymphatic nodes to predict axillary lymphatic node metastasis in breast cancer.
    Tang Y; Che X; Wang W; Su S; Nie Y; Yang C
    Med Phys; 2022 Dec; 49(12):7555-7566. PubMed ID: 35869750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
    Kim WH; Kim HJ; Park HY; Park JY; Chae YS; Lee SM; Cho SH; Shin KM; Lee SY
    Ultrasound Med Biol; 2019 Mar; 45(3):702-709. PubMed ID: 30567630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 32. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
    Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI
    World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.
    Namura M; Tsunoda H; Kobayashi D; Enokido K; Yoshida A; Watanabe T; Suzuki K; Nakamura S; Yamauchi H; Hayashi N
    Clin Breast Cancer; 2019 Aug; 19(4):278-285. PubMed ID: 30975473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
    Koolen BB; Valdés Olmos RA; Wesseling J; Vogel WV; Vincent AD; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Vrancken Peeters MJ
    Ann Surg Oncol; 2013 Jul; 20(7):2227-35. PubMed ID: 23456316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.
    Wu X; Tang L; Huang W; Huang S; Peng W; Hu D
    Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of tumor-infiltrating lymphocytes for pathological response to neoadjuvant chemotherapy in breast cancer patients with axillary lymph node metastasis.
    Yokotani T; Ikeda N; Hirao T; Tanaka Y; Morita K; Fujii T; Ohbayashi C; Nakamura T; Kobayashi T; Sho M
    Surg Today; 2021 Apr; 51(4):595-604. PubMed ID: 33052489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
    Kim WH; Lee SW; Kim HJ; Chae YS; Jeong SY; Jung JH; Park HY; Lee WK
    Sci Rep; 2018 Feb; 8(1):3181. PubMed ID: 29453385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
    Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
    Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.
    Ha SM; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
    Acta Radiol; 2017 Oct; 58(10):1198-1205. PubMed ID: 28350255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.